Press Release September 5, 2023 DelveInsight Highlights Major Advances, Transformative Therapies, and 150+ Leading Players Wheeling the Acute Lymphocytic Leukemia Clinical Trial Pipeline Landscape
Press Release September 5, 2023 Hemophilia B Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | Amarna therapeutics, Catalyst Biosciences, Freeline
Press Release September 5, 2023 Dup15q Syndrome Market is Predicted to Exhibit Remarkable Growth During the Forecast Period (2023-2032), Analyzes DelveInsight | Hoffmann-La Roche, Takeda
Press Release September 5, 2023 Essential Thrombocythemia Pipeline Review | Latest FDA, EMA, and PMDA Approvals, Novel and Emerging Therapies, Clinical Trials, and Treatment Outlook | MorphoSys AG, Jubilant Therapeutics Inc., Kartos
Press Release September 5, 2023 Chronic Lymphocytic Leukemia Pipeline Assessment, 2023 Updates | In-depth Insights into the Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, & Clinical Trials | NovalGen Ltd, Genmab, Ascentage
Press Release September 5, 2023 Rare NRG1 Fusion Market to Exhibit Rapid Growth Rate During the Forecast Period (2023-2032), Investigates DelveInsight | Hummingbird Bioscience, Merus, Elevation Oncology
Press Release September 5, 2023 Gene and Cell Therapies Targeting CNS Disorders Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight
Press Release September 5, 2023 Triple Negative Breast Cancer Pipeline Drugs Analysis Report (2023 Updates): FDA Approvals, Clinical Trials, Therapies, Mechanism of Action, Route of Administration by DelveInsight | HiberCell, Inc